Cargando…
Bendamustine and pneumocystis pneumonia: A systematic review
BACKGROUND: Bendamustine, a bifunctional mechlorethamine alkylating agent, is used in the treatment of patients with hematologic malignancies. Myelosuppression and cytotoxic effect arises quite often after bendamustine treatment. To date, there have been no recommendations for routine chemoprophylax...
Autores principales: | Hakamifard, Atousa, Mardani, Masoud, Nasiri, Mohammad Javad, Gholipur‐Shahraki, Tahereh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059183/ https://www.ncbi.nlm.nih.gov/pubmed/35509412 http://dx.doi.org/10.1002/hsr2.610 |
Ejemplares similares
-
Hemophagocytic lymphohistiocytosis presented with fever of unknown origin: A case study and literature review
por: Hakamifard, Atousa, et al.
Publicado: (2021) -
Electrolyte abnormalities in hospitalized COVID‐19 patients at tertiary referral centers in Tehran: Hypermagnesemia as a marker of fatality: A retrospective cross‐sectional study
por: Mardani, Sayna, et al.
Publicado: (2023) -
Effects of Carnitine on Nutritional Parameters in Patients with Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis
por: Gholipur-Shahraki, Tahereh, et al.
Publicado: (2018) -
Crimean‐Congo hemorrhagic fever in the COVID‐19 pandemic: A case study
por: Mardani, Masoud, et al.
Publicado: (2022) -
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction‐based diagnosis in patients receiving bendamustine
por: Rice, Mikhaila L., et al.
Publicado: (2021)